Webinar | Nestlé and Arla are leading GLP-1 food innovation. Is your R&D keeping up?​ Register Now

SygnaMap

SYGNAMAP uses spatial omics and AI to develop precision diagnostics and therapeutics for complex diseases.
2020
1-10
San Antonio, Texas, United States
  • Drug Discovery and Development
  • Pathology & Diagnostics
  • Personalized Medicine Technologies

People

Founders

Something missing or incorrect on this page? Help us enrich this information